136 related articles for article (PubMed ID: 29113360)
1. microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function.
Yang Z; Feng Z; Gu J; Li X; Dong Q; Liu K; Li Y; OuYang L
Oncotarget; 2017 Oct; 8(46):80981-80993. PubMed ID: 29113360
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J
Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687
[TBL] [Abstract][Full Text] [Related]
3. LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.
Huang L; Luan T; Chen Y; Bao X; Huang Y; Fu S; Wang H; Wang J
J Cancer; 2018; 9(6):1017-1024. PubMed ID: 29581781
[TBL] [Abstract][Full Text] [Related]
4. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
Wang L; Liu H
Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells.
Zou GP; Yu CX; Shi SL; Li QG; Wang XH; Qu XH; Yang ZJ; Yao WR; Yan DD; Jiang LP; Wan YY; Han XJ
J Cancer; 2021; 12(24):7358-7373. PubMed ID: 35003356
[TBL] [Abstract][Full Text] [Related]
6. miR-128-3p alleviates airway inflammation in asthma by targeting SIX1 to regulate mitochondrial fission and fusion.
Liu X; Cui H; Bai Q; Piao H; Song Y; Yan G
Int Immunopharmacol; 2024 Mar; 130():111703. PubMed ID: 38422767
[TBL] [Abstract][Full Text] [Related]
7. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1.
Li HL; Sun JJ; Ma H; Liu SJ; Li N; Guo SJ; Shi Y; Xu YY; Qi ZY; Wang YQ; Wang F; Guo RM; Liu D; Xue FX
Oncol Lett; 2019 Oct; 18(4):3792-3802. PubMed ID: 31579409
[TBL] [Abstract][Full Text] [Related]
9. miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression.
Chu Y; Jiang M; Du F; Chen D; Ye T; Xu B; Li X; Wang W; Qiu Z; Liu H; Nie Y; Liang J; Fan D
FEBS Open Bio; 2018 Feb; 8(2):189-200. PubMed ID: 29435409
[TBL] [Abstract][Full Text] [Related]
10. miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.
Xie X; Huang Y; Chen L; Wang J
Oncol Lett; 2018 Nov; 16(5):6697-6704. PubMed ID: 30405811
[TBL] [Abstract][Full Text] [Related]
11. MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3.
Wu H; Xiao Z; Zhang H; Wang K; Liu W; Hao Q
Anticancer Drugs; 2014 Aug; 25(7):799-809. PubMed ID: 24686007
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3.
Zhu D; Yuan D; Guo R; Zhang L; Guo T; Zhao Y; Wang J; Chen X; Qian H; Ge H
Oncol Lett; 2019 Jul; 18(1):402-410. PubMed ID: 31289511
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
14. miR-23a-3p/SIX1 regulates glucose uptake and proliferation through GLUT3 in head and neck squamous cell carcinomas.
Wang H; Xue W; Ouyang W; Jiang X; Jiang X
J Cancer; 2020; 11(9):2529-2539. PubMed ID: 32201523
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells.
Zhao Y; Dong Q; Wang E
Onco Targets Ther; 2017; 10():1049-1058. PubMed ID: 28255248
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.
Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y
Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
19. miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
Wang H; Zhang W; Zuo Y; Ding M; Ke C; Yan R; Zhan H; Liu J; Wang J
Tumour Biol; 2015 Dec; 36(12):9631-40. PubMed ID: 26150338
[TBL] [Abstract][Full Text] [Related]
20. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.
Ma Z; Cai H; Zhang Y; Chang L; Cui Y
Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
